Dr. Rodolfo E. Bordoni, MD | Atlanta ...

Dr. Rodolfo E. Bordoni

Claim this profile

Northside Hospital

Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
14 reported clinical trials
29 drugs studied

Area of expertise

1

Lung Cancer

Rodolfo E. Bordoni has run 9 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage III
Stage II
2

Non-Small Cell Lung Cancer

Rodolfo E. Bordoni has run 4 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:

Stage IV
Stage III
Stage II

Affiliated Hospitals

Image of trial facility.

Northside Hospital

Image of trial facility.

Northside Hospital - Duluth

Clinical Trials Rodolfo E. Bordoni is currently running

Image of trial facility.

Immunotherapy + Chemotherapy

for Non-Small Cell Lung Cancer

This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.

Recruiting

2 awards

Phase 3

27 criteria

Image of trial facility.

Stereotactic Radiosurgery vs Whole-Brain Radiotherapy

for Brain Metastasis from Lung Cancer

This phase III trial compares the effect of stereotactic radiosurgery to standard of care memantine and whole brain radiation therapy that avoids the hippocampus (the memory zone of the brain) for the treatment of small cell lung cancer that has spread to the brain. Stereotactic radiosurgery is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor and may cause less damage to normal tissue. Whole brain radiation therapy delivers a low dose of radiation to the entire brain including the normal brain tissue. Hippocampal avoidance during whole-brain radiation therapy (HA-WBRT) decreases the amount of radiation that is delivered to the hippocampus which is a brain structure that is important for memory. The drug, memantine, is also often given with whole brain radiotherapy because it may decrease the risk of side effects related to thinking and memory. Stereotactic radiosurgery may decrease side effects related to memory and thinking compared to standard of care HA-WBRT plus memantine.

Recruiting

2 awards

Phase 3

15 criteria

More about Rodolfo E. Bordoni

Clinical Trial Related

3 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 3 Active Clinical Trials

Treatments Rodolfo E. Bordoni has experience with

  • Pembrolizumab
  • Carboplatin
  • Nivolumab
  • Paclitaxel
  • Pemetrexed
  • Cisplatin

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Rodolfo E. Bordoni specialize in?

Is Rodolfo E. Bordoni currently recruiting for clinical trials?

Are there any treatments that Rodolfo E. Bordoni has studied deeply?

What is the best way to schedule an appointment with Rodolfo E. Bordoni?

What is the office address of Rodolfo E. Bordoni?

Is there any support for travel costs?